On Wednesday, AT&T Inc. (NYSE:T)’s shares declined -0.44% to $33.60.
AT&T Inc. (T) offered -19.30% EPS for prior five years. The company has 6.00% return on equity value while its ROI ratio was 4.90%. The company has $207.60 billion market capitalizations and the institutional ownership was 46.60%. Its price to book ratio was 2.01. Volatility of the stock was 1.10% for the week while for the month booked as 1.17%.
AT&T Inc. is a holding company. The Company provides telecommunications services. Its services and products comprise wireless communications, data/broadband and Internet services, video services, local exchange services, long-distance services, telecommunications equipment, managed networking and wholesale services.
Cemex SAB de CV (ADR) (NYSE:CX)’s shares dropped -3.17% to $7.49.
Cemex SAB de CV (ADR) (CX) has beta value of 2.75. The company has the market capitalization of $10.48 billion. Return on assets ratio of the company was -1.40% while its return on equity ratio was -5.00%. ATR value of company was 0.28 while stock volatility for week was 2.77% while for month was 3.91%. Debt to equity ratio of the company was -1.86 and its current ratio was -0.90.
CEMEX, S.A.B. de C.V. (CEMEX) is an operating and holding company engaged, directly or indirectly, through its operating auxiliaries, primarily in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates, clinker and other construction materials throughout the world, and that provides construction-related services to customers and communities in more than 50 countries throughout the world.
At the end of Wednesday’s trade, Bristol-Myers Squibb Co (NYSE:BMY)‘s shares dipped -2.16% to $62.51.
Bristol-Myers Squibb Co (BMY) is currently valued at $106.54 billion. The company has 1.66 million shares outstanding and 73.50% shares of the company were owned by institutional investors. The company has 6.36 value in price to sale ratio while price to book ratio was recorded as -6.89. The company exchanged hands with 8.10 million shares as compared to its average daily volume of 8.37 million shares. It beta stands at 0.43.
Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products across the world. The Company’s products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Company manufactures its products in the United States, Puerto Rico and in six foreign countries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
